EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management

Vasiliki Katsi, Ilias Papakonstantinou iD, Konstantinos Tsioufis

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411786 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Vasiliki Katsi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hippokration Hospital, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Metabolic Syndrome, Diabetes Mellitus, Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 352 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The involvement of cardiovascular disease in cancer onset and development represents a contemporary interest in basic science. It has been recognized, from the most recent research, that metabolic syndrome-related conditions, ranging from atherosclerosis to diabetes, elicit many pathways regulating lipid metabolism and lipid signaling that are also linked to the same framework of multiple potential mechanisms for inducing cancer. Otherwise, dyslipidemia and endothelial cell dysfunction in atherosclerosis may present common or even interdependent changes, similar to oncogenic molecules elevated in many forms of cancer. However, whether endothelial cell dysfunction in atherosclerotic disease provides signals that promote the pre-clinical onset and proliferation of malignant cells is an issue that requires further understanding, even though more questions are presented with every answer. Here, we highlight the molecular mechanisms that point to a causal link between lipid metabolism and glucose homeostasis in metabolic syndrome-related atherosclerotic disease with the development of cancer. The knowledge of these breakthrough mechanisms may pave the way for the application of new therapeutic targets and for implementing interventions in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeDiabetes MellitusAtherosclerosisCardiovascular DiseasesNeoplasmsHumans

Stichwörter der Autor:innen

adiposityatherosclerosisautophagycancer metabolismendothelial dysfunctionglycationlipoprotein metabolismmetabolic syndromeoncogenic signalsoxidative stressoxidized lipids

Autor:innen und Institutionen

  • Department of Cardiology, Hippokration Hospital, 11527 Athens, Greece.
  • 4th Department of Internal Medicine, Evangelismos Hospital, 10676 Athens, Greece.
  • School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Ilias Papakonstantinou

Zitieren

APA

Katsi, V., Papakonstantinou, I., & Tsioufis, K. (2023). Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411786

Vancouver

Katsi V, Papakonstantinou I, Tsioufis K. Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411786

BibTeX
@article{Katsi2023,
  author = {Katsi, Vasiliki and Papakonstantinou, Ilias and Tsioufis, Konstantinos},
  title = {Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411786}
}
Kostenlos starten →